Almirall Archives • NCK Pharma

Tildrakizumab (Ilumetri): Discovery, Development to Commercialization Case Study

Posted on19 Sep 2018

TagsAlmirall, case study on drug discovery to commercialization, Drug Discovery and Development Pathway, MAB, Tildrakizumab

Comments0

Brand Name: Ilumetri Biomolecule: Tildrakizumab Tildrakizumab was designed to block interleukin-23, a cytokine that plays an important role in managing the immune...

Sun Pharma and Almirall enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

Posted on29 Jul 2016

TagsAlmirall, Sun Pharma, Tildrakizumab

Comments0

Sun Pharma has a licensing agreement on the development and commercialization of tildrakizumab for psoriasis in Europe. Tildrakizumab is an investigational IL-23p19...

Grünenthal Group to Acquire Almirall de Mexico, S.A. de C.V.

Posted on17 Mar 2016

TagsAlmirall, Grünenthal, Grünenthal de Mexico, Grünenthal Group to Acquire Almirall de Mexico, S.A. de C.V.

Comments0

Grünenthal Group announced today to have entered into a definitive agreement with Almirall Group under which Grünenthal will acquire 100% of the...